Health Equity And Access

The concept of health equity did not arise in a vacuum; rather, it emerged from centuries of documented disparities in disease burden, access to care, and health outcomes across racial, socioeconomic, and geographic lines. In the United States, the intersection of slavery, segregation, and systematic exclusion from medical institutions created deeply embedded structural inequities that persist to this day. Early public health efforts in the 19th century, while groundbreaking in addressing infectious disease, often reinforced existing power hierarchies and ignored the needs of marginalized communities. The formal recognition that social determinants of health drive outcomes more than clinical interventions alone represented a paradigm shift in how healthcare professionals—including pharmacists—conceptualize their role in society.

These historical milestones demonstrate that health equity is not simply an aspirational ideal but an evolving policy and practice framework. For pharmacists preparing for the NAPLEX and clinical practice, the critical question remains: how can pharmaceutical professionals identify, measure, and actively mitigate disparities in medication access, adherence, and outcomes within the communities they serve? This lesson addresses that question by examining the core principles, frameworks, and practical strategies that underpin equitable pharmacy practice.

Before examining specific strategies, it is essential to distinguish between terms that are frequently—and incorrectly—used interchangeably. Health equality refers to providing every individual with the same resources and opportunities, while health equity requires distributing resources according to need so that every person can attain their highest possible level of health. Health equity explicitly acknowledges that different populations start from different positions due to historical and structural disadvantage. Health disparities are the measurable differences in health outcomes and their determinants between population segments, while health access encompasses the timely use of personal health services to achieve the best health outcomes, including factors such as insurance coverage, geographic proximity to providers, affordability of medications, and cultural competency of care.

The diagram above represents an ecological model adapted for pharmacy practice. At the center lies the individual patient and their ultimate health outcome. Surrounding this core are three concentric rings of influence. The innermost ring captures individual-level factors such as health literacy, language preference, and medication adherence behaviors. The middle ring represents community-level factors including the presence or absence of pharmacies, transportation infrastructure, and neighborhood safety. The outermost ring encompasses structural and policy factors such as insurance coverage mandates, formulary design, drug pricing legislation, and institutional racism. Pharmacists who understand this multilevel framework can identify leverage points at each layer—from individual counseling to community-based screening events to advocacy for policy change.

While health equity may seem primarily qualitative, there are well-established quantitative methods for measuring and tracking health disparities. Pharmacists should be familiar with several key metrics that appear in public health reporting and quality improvement programs. Understanding these metrics enables pharmacists to evaluate whether their interventions are actually reducing inequities or merely improving aggregate outcomes while leaving gaps intact.

Disparity Metrics Used in Pharmacy Quality Programs

CMS Star Ratings, which directly affect Medicare Advantage plan reimbursement, now include health equity measures. Beginning in 2024, CMS introduced the Health Equity Index (HEI) as a reward factor in the Star Rating system, incentivizing plans that perform well among enrollees receiving low-income subsidies. Pharmacists working in managed care, health-system pharmacy, or community pharmacy settings should understand that stratified quality measurement—breaking down aggregate PDC or other adherence metrics by demographic subgroups—is the foundational step in identifying where disparities exist and targeting interventions accordingly.

Barriers to medication access are multidimensional and often intersecting. A patient who lives in a pharmacy desert—a geographic area where residents must travel significant distances to reach a pharmacy—may also face limited public transportation, lower income, and reduced health literacy. These compounding barriers create cascading effects on adherence, disease management, and emergency utilization rates. Understanding these barriers is essential for pharmacists seeking to intervene effectively.

Consider the following clinical scenario that integrates disparity identification, metric calculation, and intervention design—the type of integrated thinking the NAPLEX increasingly tests.

Pharmacists are uniquely positioned among healthcare professionals to address health equity because of their accessibility, frequency of patient encounters, and expertise in medication management. Community pharmacies, in particular, are often the most accessible healthcare touchpoints in underserved areas. However, each intervention strategy carries both strengths and limitations that must be understood in context.

The regulatory and policy environment surrounding health equity in pharmacy is evolving rapidly. Pharmacists must understand both current policy frameworks and emerging trends that will reshape practice in the coming years. The shift from volume-based to value-based reimbursement inherently elevates the importance of equity, because quality measures stratified by demographics expose disparities that aggregate metrics conceal. This section compares the current state of pharmacy equity policy with the emerging advanced framework.

Looking forward, pharmacists will increasingly be expected to function not only as medication experts but as population health managers who leverage data to identify at-risk subgroups, design targeted interventions, and advocate for policy changes that address root causes of inequity. The integration of SDOH Z-codes (ICD-10-CM codes Z55–Z65) into pharmacy documentation systems will enable more precise measurement of social risk factors and their impact on medication outcomes, creating a feedback loop between clinical practice and equity-focused quality improvement.